Friday, February 05, 2021 12:10:52 AM
GEM gets 7.5%+ $ of the NRXP deal when it closes and lots of stock.
GEM financed (1.3B, - 37% of OS) RLF for development of RLF-100, Trials and Patent.
GEM wants $$$ for their efforts... NRXP/RLFACER on the NASDAQ, IMO... Money talks, the RLF-100 Patent Rocks, SPAC wont balk.
VANSBIT, SEE THE RLFNRX PR 2-4-21.?.?.
https://moneymidnight.com/2021/02/rlftf-stock-relief-therapeutics-partner-neurorx-brpa-to-begin-phase-2-3-inhaled-zyesami-covid-19-study/
All development costs under the agreement are paid by Relief, providing NeuroRx with non dilutive development capital through drug approval"
Zyesami" Relief also holds a patent issued in the United States and various other countries covering potential formulations of RLF-100TM"
PickleJar Debuts Nationwide Contest With Brian Kelley for Fans to Win a Three-Day Bahama Cruise • NREG • Jun 3, 2024 8:45 AM
ILUS Provides an Update on the Binding Term Sheet Signed with Actelis Networks (NASDAQ: ASNS) • ILUS • May 31, 2024 12:52 PM
Element79 Gold To Provide Summary and Update on Active Exploration Program, Community Relations at RMEC on June 4 • ELEM • May 30, 2024 1:18 PM
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM
ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM